Cas:959616-36-5 1,5-Naphthyridin-2(1H)-one, 7-bromo manufacturer & supplier

Chemical Name:1,5-Naphthyridin-2(1H)-one, 7-bromo

CAS.NO:959616-36-5

Synonyms:7-Bromo-1,5-naphthyridine-2(1H)-one;7-bromo-1,5-naphthyridin-2(1H)-one

Molecular Formula:C₈H₅BrN₂O

Molecular Weight:225.04200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:396.1±42.0 °C (760 mmHg)

Density:1.711±0.06 g/cm3 (20 °C, 760 mmHg)

Index of Refraction:

PSA:45.75000

Exact Mass:223.95900

LogP:1.68560

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 7-Bromo-1,5-naphthyridine-2(1H)-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-bromo-1,5-naphthyridin-2(1H)-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-bromo-1,5-naphthyridin-2(1H)-one Use and application,7-bromo-1,5-naphthyridin-2(1H)-one technical grade,usp/ep/jp grade.

Related News: Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions. 1,5-Naphthyridin-2(1H)-one, 7-bromo manufacturer Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions. 1,5-Naphthyridin-2(1H)-one, 7-bromo supplier Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations. 1,5-Naphthyridin-2(1H)-one, 7-bromo vendor Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity. 1,5-Naphthyridin-2(1H)-one, 7-bromo factory Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.